Regression of fibrosis and cirrhosis in chronic HCV patients treated with interferon based therapy

被引：0
|
作者：
Metwally, MA
Zein, CO
Zein, NN
机构：
来源：
GASTROENTEROLOGY | 2002年 / 123卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [21] Predictive value of rapid virological response in patients with HCV cirrhosis treated with pegylated interferon and ribavirin
    Basso, M.
    Giannini, E. G.
    Torre, E.
    Picciotto, A.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 : S110 - S110
  • [22] IMPROVEMENT OF ADVANCED LIVER FIBROSIS AND REGRESSION OF LIVER CIRRHOSIS IN PATIENTS WITH HEPATITIS C GENOTYPE 1 AFTER HCV PROTEASE INHIBITOR-BASED TRIPLE THERAPY
    Saez-Royuela, F.
    Linares, P.
    Cervera, L. A.
    Almohalla, C.
    Jorquera, F.
    Garcia, I.
    Moncada, A.
    Karpman, G.
    Badia, E.
    Vallecillo, M. A. A.
    Lorenzo, S.
    Olcoz, J. L.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S594 - S594
  • [23] Effects of interferon therapy on fibrosis serum markers in HCV-positive chronic liver disease
    Mazzoran, L
    Tamaro, G
    Mangiarotti, MA
    Marchi, P
    Baracetti, S
    Gerini, U
    Fanni-Cannelles, M
    Zorat, F
    Pozzato, G
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (02) : 125 - 131
  • [24] Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program
    Gray, E.
    O'Leary, A.
    Bergin, C.
    Cannon, M.
    Courtney, G.
    Crosbie, O.
    De Gascun, C. F.
    Fanning, L. J.
    Feeney, E.
    Houlihan, D. D.
    Kelleher, B.
    Lambert, J. S.
    Lee, J.
    Mallon, P. W. G.
    McConkey, S.
    McCormick, A.
    McKiernan, S.
    McNally, C.
    Murray, F.
    Sheehan, G.
    Stewart, S.
    Walsh, C.
    Norris, S.
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (06) : 593 - 601
  • [25] Effect of sustained viral response on the regression of fibrosis and portal hypertension in cirrhotic HCV patients treated with Oral antiviral therapy.
    Mehrotra, Puneet
    Mehrotra, Pulkit
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 753 - 753
  • [26] INFLUENCE OF SUSTAINED VIRAL RESPONSE IN THE REGRESSION OF FIBROSIS AND PORTAL HYPERTENSION IN CIRRHOTIC HCV GENOTYPE 1 PATIENTS TREATED WITH TRIPLE THERAPY
    Puente, A.
    Cabezas, J.
    Arias Loste, M. T.
    Estebanez, A.
    Fortea, J. I.
    Cuadrado, A.
    Fabrega, E.
    Casafont, F.
    Crespo, J.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S361 - S362
  • [27] Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy
    Mauss, S
    Valenti, W
    DePamphilis, J
    Duff, F
    Cupelli, L
    Passe, S
    Solsky, J
    Torriani, FJ
    Dieterich, D
    Larrey, D
    [J]. AIDS, 2004, 18 (13) : F21 - F25
  • [28] Hepatic decompensation associated with an interferon-free antiviral therapy in patients with HCV-cirrhosis
    Batskikh, S. N.
    Vinnitskaya, E. V.
    Sandler, Yu G.
    Khaimenova, T. Yu
    [J]. TERAPEVTICHESKII ARKHIV, 2018, 90 (11): : 67 - 73
  • [29] Interferon therapy for prevention of hepatocellular cancer in patients with HCV related cirrhosis: A meta-analysis.
    Papadimitropoulos, V
    Papatheodoridis, GV
    Hadziyannis, SJ
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1478 - A1478
  • [30] Regression of Advanced Fibrosis or Cirrhosis Measured by Elastography in Patients with Chronic Hepatitis C who Achieve Sustained Virologic Response after Treatment for HCV
    Crissien, Ana Maria
    Minteer, William B.
    Pan, Jason J.
    Frenette, Catherine T.
    Pockros, Paul J.
    [J]. HEPATOLOGY, 2015, 62 : 264A - 265A
12345